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Abstract
Background: High dose radiation therapy is commonly used in maxillofacial surgeries to treat a number of head
and neck tumors. Despite its widespread use, little information is available regarding the effects of irradiation on
bone cell viability and release of growth factors following dose-dependent irradiation.
Methods: Bone samples were collected from porcine mandibular cortical bone and irradiated at doses of 0, 7.5, 15,
30, 60 and 120 Grays. Thereafter, cell viability was quantified, and the release of growth factors including TGFβ1,
BMP2, VEGF, IL1β and RANKL were investigated over time.
Results: It was observed that at only 7.5Gy of irradiation, over 85 % of cells were non-vital and by 60 Gy, all cells
underwent apoptosis. Furthermore, over a 7-fold decrease in VEGF and a 2-fold decrease in TGFβ1 were observed
following irradiation at all tested doses. Little change was observed for BMP2 and IL1β whereas RANKL was
significantly increased for all irradiated samples.
Conclusions: These results demonstrate the pronounced effects of irradiation on bone-cell vitality and subsequent
release of growth factors. Interestingly, the largest observed change in gene expression was the 7-fold decrease in
VEGF protein following irradiation. Future research aimed at improving our understanding of bone following
irradiation is necessary to further improve future clinical treatments.
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Background
High doses of irradiation therapy are routinely adminis-
tered to patients for a large number of cancers affecting
many organs [1, 2]. Furthermore, the use of bone allo-
grafts necessitates high dose irradiation for sample
sterilization [1, 2]. Under normal circumstances, irradi-
ation passes through a number of tissues where the
minimization of doses is vital to the future survival of
tissues. One tissue that commonly receives high doses of
irradiation therapy in maxillofacial surgery is that of
bone. Due to the high volume of bones found in the
maxilla, it is common in head and neck procedures to
pass high doses of irradiation through bony tissues [1, 2].
Common doses can range from 60 Gray to 70 Grays and
such procedures have been highly successful for the treat-
ment of many head and neck tumors [3, 4]. Despite suc-
cessfully treating and managing these tumors, irradiation
of bone has reported some drawbacks with a certain per-
centage of bone losing complete vitality and becoming
necrotic [3, 4]. A group of experts have since recom-
mended guidelines established for preventing the possibil-
ity of developing osteoradionecrosis of the jaw at doses
exceeding 60 Grays [3, 4].
Furthermore, irradiation of bone is also commonly
found in bone allograft sterilization procedures for bone
tissue banking [5]. Although the full set of doses are
commonly kept proprietary information [5], the release
of subsequent growth factors from its content is a
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trademark commonly observed in demineralized bone
allografts which may demonstrate signs of osteoinduc-
tion by showing signs of ectopic bone formation in vari-
ous animal models. Irradiation of bone is also used in
extracorporeal irradiation and has been implicates in not
only oral and maxillofacial surgery, but also other disci-
plines such as otolaryngology [6] and orthopedics [7].
Marx et al. have been key oral maxillo-facial surgeons
responsible for treating and developing treatment guide-
lines for patients presenting necrotic bone following ir-
radiation [8–10]. While a number of attempts have been
investigated to maintain optimal bone viability [11–13],
a limited understanding of the cellular events that take
place within bone following irradiation would benefit
from further investigation.
Due to the widespread use of irradiation for various
bone procedures including irradiation for tumors,
sterilization of autologous bone transplants and bone tis-
sue banking, it became of interest to our group to further
investigate in a bench model the effects of dose-
dependent irradiation on bone cell viability and release of
growth factors. While it is known that irradiation is un-
favorable for bone remodeling [14] and that an accumula-
tion of evidence has been accumulating demonstrating
that irradiation consequently affects microvasculature of
bone-tissues [15], a detailed investigation of the in vitro
mechanisms was studied to further increase our under-
standing of bone changes following irradiation. Therefore,
the purpose of the present investigation was to determine
the effects of irradiation on bone cell viability following ir-
radiation at various single-doses including 0, 7.5, 15, 30,
60 and 120 Grays. Thereafter, bone graft morphology and
surface proteins were analyzed via scanning electron mi-
croscopy and release of growth factors from the bone
samples was quantified for TGFβ1, BMP2, VEGF, IL1β
and RANKL at 15 min and 4 h following irradiation.
Methods
Bone collection
Bone was obtained from adult pigs (Metzgerei Balsiger,
Wattenwil, Switzerland) and harvested from the buccal-
sided mandibular cortical bone with a “bone scraper”
(Hu-Friedy, Rotterdam, Netherlands) and placed into
sterile plastic dishes as previously described [16]. There-
after, bone was irradiated (single-dose) at the following
doses: 0 (control), 7.5, 15, 30, 60 and 120 Grays. Briefly,
bone samples were collected and exposed to 137Cs γ-
rays at the dose rate of 0.83 Gy/min using a Gamma-
cell®40 Exactor (Best Theratronics, Ottawa, Canada) for
0, 9, 18, 36, 72 and 144 min until the final dose of irradi-
ation was reached. Thereafter, bone samples were imme-
diately placed in a cell culture hood and experiments
performed. For each experiment, four independent prep-
arations of bone samples were available and all samples
were performed in triplicate. Thereafter bone samples
were either 1) fixed and assigned to scanning electron
microscopy, 2) assigned for MTS analysis for cell viabil-
ity or 3) left in PBS solution and samples collected after
15 min and 4 h for protein quantification using ELISA.
Scanning electron microscopy
Bone samples were fixed in 1 % glutaraldehyde and 1 %
formaldehyde for 2 days for scanning electron micros-
copy (SEM). Following serial dehydration with ethanol,
samples were critical point dried (Type M.9202 Critical
Point Dryer, Roth & Co. Hatfield, PA, USA) and allowed to
dry overnight as previously described [17, 18]. The follow-
ing day, samples were sputter coated using a Balzers Union
Sputtering Device (DCM-010, Balzers, Liechtenstein) with
10 nm of gold and analyzed microscopically using a Philips
XL30 FEG scanning electron microscope to determine sur-
face variations between samples.
Quantification of viable cells in bone samples
The cell viability in each of the bone samples was deter-
mined using the CellTiter 96® One Solution Cell Assay
(MTS) (Promega, Madison, WI, USA) as previously de-
scribed [19]. Briefly, 100 mg of harvested bone was
treated with 80 μL of CellTiter96 aqueous solution dis-
solved in 400 μL of PBS. After 4 h of incubation, the cell
viability was determined by measuring the absorbance at
490 nm on a 96-well plate-reader. Experiments were
performed in triplicate with three independent experi-
ments for each condition. Data was normalized to sam-
ples at 120 Gray with no signs of cell viability and
analyzed for statistical significance using one-way ana-
lysis of variance with Tukey’s test.
ELISA protein quantification
Specific protein contents were determined for cell cul-
ture media incubated with 250 mg of bone samples. At
time points 15 min and 4 h BMP2, TGFβ1, VEGF, IL1β
and RANKL were quantified using an ELISA assays
(RND Systems, Minneapolis, MN, USA) according to
manufacturer’s protocol as previously described [17, 20].
Briefly, 100 μl of assay diluents and 50 μl of sample were
incubated for 2 h at room temperature in antibody-
precoated 96-well plates. Wells were washed 4 times
with washing buffer, incubated for 2 h with peroxidase-
conjugated antibody solution, washed again, followed by
addition of 200 μl of substrate solution for 30 min and
50 μl of stopping solution for 30 min. Absorbance was
measured at 450 nm on an Infinite 200 microplate
reader (Tecan Group LTD, Männedorf, Switzerland). All
samples were measured in triplicate and 3 independent
experiments were performed. Statistical analysis was per-
formed by two-way ANOVA with Bonferroni test.
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Results
Scanning electron microscopy
Bone samples were first visualized by SEM for morpho-
logic differences before and after irradiation (Figs. 1, 2).
Control samples were first utilized to determine surface
characteristics prior to irradiation (Fig. 1). It was ob-
served at 25 times magnification that bone samples pre-
sented many roughened topographies (Fig. 1). At higher
resolution (400x magnification), the surface of control
bone samples demonstrated many visible proteins on the
surface of bone samples with a homogeneous surface
coating of proteins typically found in native bone (Fig. 1).
Following irradiation, bone samples visualized by SEM
demonstrated a very homogeneous layer of surface pro-
teins remaining on the bone surface (Fig. 2). Under the
present conditions, very little change could be observed
for bone samples at all doses with a common protein
layer found across all surfaces independent of irradiation
doses up to 120 Gy (Fig. 2).
Cell viability within bone samples
Bone samples were quantified by MTS assay in order to
determine the amount of living bone cells found within
samples following irradiation at doses ranging from 0 to
120 Gy. After only 7.5 Gy of irradiation, it was observed
that over 85 % of all cells found within bone samples
were non-vital (Fig. 3). After 60 Gy of irradiation, it was
found that 0 % of cells were still viable (Fig. 3). The re-
sults from this experiment confirm the extremely dam-
aging and significant effect of even small doses of
irradiation on vitality of cells found within the bone
matrix (Fig. 3).
Release of growth factors from within bone samples
All bone samples were then quantified for release of
growth factors including VEGF, TGFβ1, BMP2, RANKL
and IL1β following 15 min and 4 h (Fig. 4, 5). It was first
found that a high concentration of VEGF of 1517 +/-
142 pg/mL could be observed for control samples at
15 min and this was relatively maintained following 4 h
of sample preparation (Fig. 4a). Interestingly, a marked
and pronounced significant decrease of VEGF was ob-
served in all irradiated bone following as little as 7.5 Gy
of irradiation (Fig. 4a). No significant differences could
be observed between all samples irradiated with bone at
either 15 min or 4 h (Fig. 4a). Then TGFβ1 was quanti-
fied and although no significant differences could be ob-
served at 15 min post irradiation, approximately a 2 fold
significant increase was observed for control samples at
4 h (4621 +/- 1058 pg/mL). Interestingly, no differences
in BMP2 protein concentration could be observed at
both time points with very little expression observed in
all samples (control samples = 127 +/- 15 pg/mL at
15 min and 146 +/- 30 pg/mL at 4 h).
Following growth factor concentration analysis, IL1β
and RANKL were then quantified for the effects of bone
irradiation on inflammatory cytokines and osteoclast dif-
ferentiation marker (Fig. 5). First it was found that at
15 min post irradiation, no differences in RANKL expres-
sion could be observed between control samples and all ir-
radiated bone samples (Fig. 5a). By 4 h, a significantly
lower expression of RANKL could be observed when
compared to all irradiated bone samples although all re-
sults were less than a 2 fold significant increase (Fig. 5a).
No differences could be observed between all samples at
either time points for IL1β expression (Fig. 5b).
Discussion
The purpose of the present manuscript was to determine
in detail the cellular events that occur following irradi-
ation of bone samples at increasing doses. Although
clinically doses can range in intensity and duration, it
has been suggested in the literature that doses exceeding
60 Gy are more commonly associated with osteoradione-
crosis of the jaw [3, 4]. Furthermore, a number radiation
therapy complications have been reported in the litera-
ture to date [21]. Therefore, the aim of this bench top
study was to perform an in vitro investigation to further
understand the cellular events taking place within bone
samples following irradiation.
Interestingly, in the present study very little change in
surface proteins was found between all bone samples
Fig. 1 Scanning electron micrograph (SEM) of control bone samples at magnifications of both 25 times and 400 times. Note the visible protein
content found on the surface of bone at a 400 times magnification
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following irradiation (Figs. 1, 2). Furthermore, it was ob-
served that in all samples treated with irradiation, over
an 85 % cell mortality was seen even following as little
as 7.5 Gy (Fig. 3). This result was extremely surprising
as it was initially thought that such small doses would
have very little effect on cellular viability. It must be
noted that this reported finding applies solely to an in
vitro model and its extrapolation to the clinical reality is
limited given that immune cells and regenerative cells
would minimize free radicals and cells death when com-
pared to the present in vitro model. Nevertheless, it re-
mains striking that cell death occurred in such high
numbers following such low levels of irradiation doses.
Thereafter, samples were investigated for growth factor
and cytokine release following irradiation at both 15 min
and 4 h post irradiation. The reason for selecting these
time points was specifically to investigate the changes in
cytokine release after a short time interval following ini-
tial irradiation (15 min) and also to determine how re-
lease of cytokines was affected after a later time point
(4 h) following cell death from irradiation. The bone
samples were first assessed for VEGF protein release.
There was a marked and significant decrease in release
of VEGF as early as 15 min post-irradiation (Fig. 4a).
VEGF is one of the key growth factors responsible for
angiogenesis and the effects of irradiation demonstrate
the harsh effects on this potent growth factor. The re-
sults from this study further demonstrate and support
the groups of clinical experts working with oxygen deliv-
ered in hyperbaric pressures for improved angiogenesis
before and/or after irradiation therapy [11–13]. Al-
though the clinical efficacy of using such treatment has
Fig. 2 Scanning electron micrograph (SEM) of irradiated bone samples at a magnification of 400 times for (a) 7.5, (b) 15, (c) 30, (d) 60 and (e) 120
Grays. Following increasing concentrations of irradiation, little to no changes in the surface homogeneity of proteins could be observed across all
irradiated samples
Fig. 3 Relative cell viability of bone cells following irradiation at
varying concentrations of Grays relative to control samples. Over
85 % of all cells were non-vital in samples receiving as little as 7.5 Gy
and all cells were non-vital following 60 Gy. (** denotes significantly
higher than all other treatment modalities p < 0.01)
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come under speculation in recent years [22], the rational
behind improving the angiogenic properties of bone for
irradiated patients is logical and can further be explained
by the present study as VEGF was the growth factor
most notably down-regulated following irradiation
(Fig. 4a). Future research aimed at addressing the in vivo
release of VEGF from bone following irradiation may
further add valuable data supporting the findings from
the present study that irradiation has a significantly
pronounced effect on VEGF protein release following ir-
radiation at various doses.
Interestingly, it has been shown in a recent report that
osteocytes are major contributors to the release of VEGF
in vivo [23]. Furthermore, a subsequent in vitro report
has demonstrated that proton irradiation with as little as
2 Gy is enough to suppress angiogenic genes in certain
cell types [24]. Taken together with the results from the
present study, it becomes extremely clinically relevant to
further design strategies to limit the down-regulation of
pro-angiogenic genes.
A second growth factor that has been extensively in-
vestigated by our group with respect to growth factor re-
leased from bone samples is TGFβ1 [17, 25–27]. In
several studies analyzing the released protein content
from bone (termed bone conditioned medium (BCM)),
it was found that one of the likely paracrine factors
Fig. 4 Elisa quantification for growth factors including (a) vascular
endothelial growth factor (VEGF), (b) transforming growth factor beta 1
(TGFB1) and (c) bone morphogenetic protein 2 (BMP2). a Following
irradiation at all doses, a marked and significant decrease in VEGF was
noted at both 15 min and 4 h. b Similarly, TGFB1 had a significant 2 fold
decrease at 4 h for irradiated samples. c No changes in BMP2 could be
observed at all time points following irradiation. (** denotes significantly
higher than all other treatment modalities p < 0.01)
Fig. 5 Elisa quantification for growth factors including (a) Receptor
activator of nuclear factor kappa-B ligand (RANKL) and (b) interleukin
1-beta (IL1B). a Following irradiation at 4 h, a 2 fold decrease in
RANKL could be observed for control samples when compared to all
irradiated doses. b No changes in IL1B could be observed at all time
points following irradiation. (# denotes significantly lower than all
other treatment modalities p < 0.01)
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displayed in bone remodeling is that of TGFβ1 [25]. It
was found that by inhibiting TGFβ1 pathway, a 5-fold de-
crease in oral fibroblast activity was observed, thus con-
firming that much of the preliminary remodeling process
caused by bone is likely governed by TGFβ1 signaling
[27]. Thus, in the present study, a 2 fold significant de-
crease in TGFβ1 protein expression released from the
bone samples following irradiation is likely to have a
significant effect on future bone remodeling following
irradiation. Furthermore, the combinatory reduction
of both TGFβ1 and VEGF is hypothesized to pose
major bone remodeling challenges further illustrating
the necessary regenerative procedure to counteract these
major drawbacks.
It was surprisingly observed in the present study that
irradiation had virtually no effect on BMP2 protein ex-
pression (Fig. 4c). It may therefore be concluded that
dying cells that are found within the bone matrix are not
target cells for release of osteoinductive growth factors
such as BMP2. Interestingly, it is commonly reported in
the literature that certain forms of demineralized freeze-
dried bone allografts (DFDBA) are osteoinductive whereas
most if not all non-demineralized samples are non-
osteoinductive [28]. Therefore, it may be concluded that
within the present investigation, BMP2 is not a key player
in bone remodeling of irradiated bone and likely BMP2
expression is only upregulated once the bone samples are
resorbed by osteoclasts and BMP2 is thereafter released
from content coming from within the bone matrix.
The results obtained with RANKL protein quantifica-
tion also generated statistically significant differences at
4 h between control and irradiated bone. RANKL pro-
tein expression was up to 2 fold lower than certain irra-
diated bone samples. It must once again be highlighted
that the largest percentage of cells found within bone
samples are osteocytes, which account for approximately
90 % of all bone cells. It has previously been demon-
strated that damaged or lack of osteocytes is routinely
associated with reduced remodeling [29, 30] and dying
osteocytes are able to signal for bone resorption by attract-
ing osteoclasts through the release of RANKL [31, 32]. The
in vitro findings in the present experiment further demon-
strate and confirm the ability for bone samples undergoing
high and fast rates of cell death are able to release osteo-
clast differentiation marker RANKL to the surrounding en-
vironment following cell death.
It must also be considered that one of the study limita-
tion of the present study were that all bone samples re-
ceived irradiation directly to bone in an in vitro model
which might not simulate a clinical situation. An in vivo
model would necessitate that all irradiation to bone
would ultimately pass through overlying tissue which in-
clude epithelial, connective tissues, glands, muscles and
a combination of them therefore absorbing some of the
irradiation prior to bone. Furthermore, immune cells
would counteract some of the free radicals produced by
irradiation likely contributing to apoptosis of various cell
types. Future investigation characterizing this interplay
between these various cell types would further contrib-
ute to our understanding of bone remodeling following
irradiation. Furthermore, in the present model, the bone
periosteum was removed which might have a significant
influence of the final outcome. Many of the progenitor
cells found within bone are located within the perios-
teum and this complex interaction between periosteum
and bone requires better understanding to better imple-
ment future regenerative procedures.
In context with some of the known literature, it has
been debated for some years the influence of osteoradio-
necrosis on bone cell interactions. The original proposed
and well-accepted ‘three-H concept’ of hypoxia, hypocel-
lularity and hypovascularity as defined by Marx brings
into question all the key elements of bone viability [33].
In light of the present findings, it becomes apparent that
one of the key components downregulated after irradi-
ation is that of VEGF thus giving evidence for a hypo-
vascular and hypoxic environment. We also demonstrate
the drastic changes in cell viability following only 7.5 Gy
of irradiated bone. Although these doses would be signifi-
cantly different in a human model and that the present in
vitro model can only be vaguely extrapolated to a clinical
situation, it remains highly pertinent information that 2 of
the most affected genes, VEGF and TGFβ1, are prominent
growth factors for bone regeneration.
Furthermore, most of the accumulated evidence from
this manuscript seems to suggest that it is the osteocytes
that are playing a key role in this process following ir-
radiation. As most of the cells are apoptotic following ir-
radiation, it becomes evident that they are major key
players in maintaining tissue vascularity as they are key
players in VEGF production. In previous histologic stud-
ies, it was found in human specimen samples from
osteoradionecrotic bone after 36 Gy, a loss of osteocytes
could be observed [34, 35]. Thus, it remains essential to
further study the relationship between irradiated bone
and most specifically osteocytes. Future research aimed
at investigating protein release of growth factors such as
TGFβ1 and VEGF using an animal model would be ex-
tremely advantageous. A further understanding of this
relationship could provide more pertinent information
to clinicians to better gear regenerative procedures for
the treatment of osteoradionecrosis of the jaw and pos-
sibly provide better preventative measures for these pa-
tients prior to complications.
Conclusions
The analysis of bone samples following irradiation demon-
strated quite profound effects on cell viability following
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irradiation and the release of growth factors responsible
for bone regrowth and/or bone remodeling were also
significantly affected. Over 85 % of cell death oc-
curred following only 7.5 Gy of irradiation to bone
samples and a 7-fold decrease of VEGF and a 2-fold de-
crease in TGFβ1 protein quantification were observed.
Furthermore, RANKL was upregulated approximately 2
fold in samples receiving irradiation. As the effects of ir-
radiation on bone viability and release of proteins was
quite pronounced in the present study, it may thus be-
comes vital to better understanding the cell mechanisms
taking place following irradiation. Future animal study
investigating growth factor release from bone follow-
ing irradiation would be beneficial.
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